The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis
Open accessAbstract
Objectives To assess the safety of intra-articular (IA) autologous tolerogenic dendritic cells (tolDC) in patients with inflammatory arthritis and an inflamed knee; to assess the feasibility and acceptability of the approach and to assess potential effects on local and systemic disease activities. Methods An unblinded, randomised, controlled, dose escalation Phase I trial. TolDC were differentiated from CD14+ monocytes and loaded with autologous synovial fluid as a source of autoantigens. Cohorts of three participants received 1×106, 3×106 or 10×106 tolDC arthroscopically following saline irrigation of an inflamed (target) knee. Control participants received saline irrigation only. Primary outcome was flare of disease in the target knee within 5 days of treatment. Feasibility was assessed by successful tolDC manufacture and acceptability via patient questionnaire. Potential effects on disease activity were assessed by arthroscopic synovitis score, disease activity score (DAS)28 and Health Assessment Questionnaire (HAQ). Immunomodulatory effects were sought in peripheral blood. Results There were no target knee flares within 5 days of treatment. At day 14, arthroscopic synovitis was present in all participants except for one who received 10×106 tolDC; a further participant in this cohort declined day 14 arthroscopy because symptoms had remitted; both remained stable throughout 91 days of observation. There were no trends in DAS28 or HAQ score or consistent immunomodulatory effects in peripheral blood. 9 of 10 manufactured products met quality control release criteria; acceptability of the protocol by participants was high. Conclusion IA tolDC therapy appears safe, feasible and acceptable. Knee symptoms stabilised in two patients who received 10×106 tolDC but no systemic clinical or immunomodulatory effects were detectable. Trial registration number NCT01352858.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regulation and Functions of the IL-10 Family of Cytokines in Inflammation and Disease
Ouyang, W., Rutz, S., Crellin, N. K., Valdez, P. A., & Hymowitz, S. G. (2011) · Annual Review of Immunology · doi:10.1146/annurev-immunol-031210-101312 · Cited by 1,925
Human interleukin-17: A T cell-derived proinflammatory cytokine produced by the rheumatoid synovium
Chabaud, M., Durand, J. M., Buchs, N., Fossiez, F., Page, G., Frappart, L., & Miossec, P. (1999) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199905)42:5<963::aid-anr15>3.0.co;2-e · Cited by 954
The role of dendritic cells in autoimmunity
Ganguly, D., Haak, S., Sisirak, V., & Reizis, B. (2013) · Nature Reviews Immunology · doi:10.1038/nri3477 · Cited by 507
Phase I (Safety) Study of Autologous Tolerogenic Dendritic Cells in Type 1 Diabetic Patients
Giannoukakis, N., Phillips, B., Finegold, D., Harnaha, J., & Trucco, M. (2011) · Diabetes Care · doi:10.2337/dc11-0472 · Cited by 407
Dendritic cells: Understanding immunogenicity
Steinman, R. M. (2007) · European Journal of Immunology · doi:10.1002/eji.200737400 · Cited by 401
Benham, H., Nel, H. J., Law, S. C., Mehdi, A. M., Street, S., Ramnoruth, N., Pahau, H., Lee, B. T., Ng, J., G. Brunck, M. E., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa9301 · Cited by 379
TH-17 cells in rheumatoid arthritis
Shahrara, S., Huang, Q., Mandelin, A. M., & Pope, R. M. (2008) · Arthritis Research & Therapy · doi:10.1186/ar2477 · Cited by 216
Jauregui-Amezaga, A., Cabezón, R., Ramírez-Morros, A., España, C., Rimola, J., Bru, C., Pinó-Donnay, S., Gallego, M., Masamunt, M. C., Ordás, I., et al. (2015) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjv144 · Cited by 167
Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?
Hilkens, C. M. U., & Isaacs, J. D. (2012) · Clinical & Experimental Immunology · doi:10.1111/cei.12038 · Cited by 158
Self-citationDevelopment of Dendritic Cell-Based Immunotherapy for Autoimmunity
Hilkens, C. M. U., Isaacs, J. D., & Thomson, A. W. (2010) · International Reviews of Immunology · doi:10.3109/08830180903281193 · Cited by 150
Self-citation
Cited by
Pathogenetic insights from the treatment of rheumatoid arthritis
McInnes, I. B., & Schett, G. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31472-1 · Cited by 1,345
The immunopathogenesis of seropositive rheumatoid arthritis: from triggering to targeting
Malmström, V., Catrina, A. I., & Klareskog, L. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2016.124 · Cited by 451
Vitamin D and Immune Regulation: Antibacterial, Antiviral, Anti‐Inflammatory
L Bishop, E., Ismailova, A., Dimeloe, S., Hewison, M., & White, J. H. (2021) · JBMR Plus · doi:10.1002/jbm4.10405 · Cited by 392
Baker, K. F., & Isaacs, J. D. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211555 · Cited by 370
Self-citationTherapeutic advances in rheumatoid arthritis
Brown, P., Pratt, A. G., & Hyrich, K. L. (2024) · BMJ · doi:10.1136/bmj-2022-070856 · Cited by 312
Metadata
- Authors
- Bell, G. M., Anderson, A. E., Diboll, J., Reece, R., Eltherington, O., Harry, R. A., Fouweather, T., MacDonald, C., Chadwick, T., McColl, E., Dunn, J., Dickinson, A. M., Hilkens, C. M. U., & Isaacs, J. D.
- Venue
- Annals of the Rheumatic Diseases
- Publisher
- Elsevier BV
- Published
- 2017-01
- Volume
- 76
- Issue
- 1
- Pages
- 227-234
- ISSN
- 0003-4967 (ISSN-L)
- OpenAlex
- W2180435160
- Cited by
- 315
- References
- 19
- FWCI
- 29.80
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis. https://app.cochat.ai/papers/10.1136/annrheumdis-2015-208456
- The paper
- Bell, G. M., Anderson, A. E., Diboll, J., Reece, R., Eltherington, O., Harry, R. A., Fouweather, T., MacDonald, C., Chadwick, T., McColl, E., Dunn, J., Dickinson, A. M., Hilkens, C. M. U., & Isaacs, J. D. (2017). Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis. Annals of the Rheumatic Diseases. https://doi.org/10.1136/annrheumdis-2015-208456
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.